← Open Payments lookup

RACHEL NEAL: Open Payments

NPI 1811401318 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,001 in 53 payments from 11 companies in 2025. Trend: 2023 $48 · 2024 $203 · 2025 $1,001

Food & beverage: $1,001
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP13$284
Bayer Healthcare Pharmaceuticals Inc.11$266
Lilly USA, LLC14$195
Novo Nordisk Inc3$54
Aimmune Therapeutics, Inc.2$47
ABBVIE INC.2$36
PFIZER INC.2$34
Phathom Pharmaceuticals, Inc.3$26
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$23
Abbott Laboratories1$22

Products named: Kerendia, AIRSUPRA, MOUNJARO, FARXIGA, Ozempic, ZENPEP, UBRELVY, BREZTRI.

Industry payments across AR — which companies pay providers there.